Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Rent the Runway Inc (RENT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Rent the Runway Inc — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $977.37M), while Rent the Runway Inc trades at $1.71 (market cap $57.68M). The key difference: Maravai LifeSciences Holdings Inc. Class A Common Stock is far larger — about 16.9× Rent the Runway Inc's market cap, and Maravai LifeSciences Holdings Inc. Class A Common Stock is trading nearer its 52-week high, Rent the Runway Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Rent the Runway Inc for 56 Days on average.
| MRVI | RENT | |
|---|---|---|
Market Cap | $977.37M | $57.68M |
Volume | 2,742,564 | 79,227 |
Sector | Health | Consumer Cyclical |
52-Week High | $9.00 | $9.39 |
52-Week Low | $2.83 | $1.55 |
Typical Hold Time | 0 Days | 56 Days |
Enterprise Value | $1.08B | $224.68M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
RENT trades at $1.78, down 2.73% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported Q2 2026 revenue of $97.7 million, up 20.8% year-over-year, and named Paige Thomas as CEO. Despite negative shareholder equity and a high debt load, profitability is improving, with net income margin turning positive in 2026. Analyst sentiment is cautiously optimistic with a 42% buy rating.
The outlook is cautiously optimistic as revenue growth accelerates and cost controls improve margins, but significant risks remain from negative equity, high debt, and ongoing legal investigations. The stock presents a high-risk, high-reward opportunity contingent on successful execution of the turnaround plan under new leadership.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Rent the Runway Inc
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.
Read more on RENT →
